Origami Therapeutics, Inc.
San Diego, CA
- UEI
- J5YECAJMZCS4
- CAGE
- 80E17
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 9276 Scranton Rd #500, San Diego, CA 92121, USA
- Website
- origamitherapeutics.com
- Founded
- 2016
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Uncovering the molecular target(s) of ORI-113, a potential brain-penetrant small molecule therapeutic for huntington's… | National Institute of Neurological Disorders and Stroke | $499,988 | |
| Characterization of small molecules that lower mutant huntingtin protein as potential therapeutics for huntington?s… | National Institute of Neurological Disorders and Stroke | $609,996 |
Quick answers
What is Origami Therapeutics, Inc.'s UEI?
Origami Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is J5YECAJMZCS4.
What is Origami Therapeutics, Inc.'s CAGE code?
Origami Therapeutics, Inc.'s CAGE code is 80E17.
What is Origami Therapeutics, Inc.'s primary NAICS code?
Origami Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Origami Therapeutics, Inc. located?
Origami Therapeutics, Inc.'s physical address in SAM.gov is 9276 Scranton Rd #500, San Diego, CA 92121, USA.
Is Origami Therapeutics, Inc. registered in SAM.gov?
Yes. Origami Therapeutics, Inc.'s SAM.gov registration is active through March 24, 2027.
What is Origami Therapeutics, Inc.'s most recent federal award?
Origami Therapeutics, Inc.'s most recent federal grant award is Uncovering the molecular target(s) of ORI-113, a potential brain-penetrant small molecule therapeutic for huntington's… (R43NS145855), from National Institute of Neurological Disorders and Stroke, on August 13, 2025.
On GovTribe
See Origami Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors